Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2003 | 09-2003 | 07-2003 | 06-2003 | 04-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -910 | -450 | -450 | -2,220 | N/A |
| Depreciation Amortization | 60 | 0 | 0 | 130 | N/A |
| Accounts receivable | 0 | N/A | 0 | N/A | 17 |
| Other Working Capital | 40 | 40 | 40 | -40 | N/A |
| Other Operating Activity | 10 | 40 | 40 | 40 | -17 |
| Operating Cash Flow | $-800 | $-370 | $-370 | $-2,090 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -5 | -5 | -30 | N/A |
| Purchase Sale Intangibles | 0 | N/A | 0 | N/A | -27 |
| Other Investing Activity | -10 | -5 | -5 | -30 | 0 |
| Investing Cash Flow | $-20 | $-10 | $-10 | $-60 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,120 | 1,010 | 1,010 | -100 | 0 |
| Financing Cash Flow | $1,120 | $1,010 | $1,010 | $-100 | $N/A |
| Beginning Cash Position | 170 | 170 | 170 | 2,440 | N/A |
| End Cash Position | 470 | 810 | 810 | 170 | N/A |
| Net Cash Flow | $290 | $630 | $630 | $-2,260 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -800 | -370 | -370 | -2,090 | N/A |
| Capital Expenditure | 0 | N/A | 0 | N/A | -38 |
| Free Cash Flow | -800 | -370 | -370 | -2,090 | -38 |